Journals / Online Türk Sağlık Bilimleri Dergisi / 2022 / Cilt: 7 - Sayı: 3

Early Detection of Gynecological Cancers and Breast Cancer During the Pandemic and Screening Tests: What Do Women Think?

Pandemi Döneminde Jinekolojik Kanserler ve Meme Kanserinin Erken Tanınması ve Tarama Testleri: Kadınlar Ne Düşünüyor?

Pages
499–505
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Objective: This descriptive and cross-sectional study was conducted to determine women’s opinions about screening tests and early detection of gynecological cancers and breast cancer during the pandemic.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This descriptive and cross-sectional study was conducted to determine women’s opinions about screening tests and early detection of gynecological cancers and breast cancer during the pandemic.
📊
Key Findings & Data:Objective: This descriptive and cross-sectional study was conducted to determine women’s opinions about screening tests and early detection of gynecological cancers and breast cancer during the pandemic.
💡
Conclusion & Impact:Objective: This descriptive and cross-sectional study was conducted to determine women’s opinions about screening tests and early detection of gynecological cancers and breast cancer during the pandemic.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Tarama testleri · kanser · jinekoloji

Abstract

Objective: This descriptive and cross-sectional study was conducted to determine women’s opinions about screening tests and early detection of gynecological cancers and breast cancer during the pandemic.

Özet

Amaç: Çalışma pandemi döneminde jinekolojik kanserler ve meme kanserinin erken tanınması ve tarama testleri hakkında kadınların görüşlerini belirlemek amacıyla tanımlayıcı ve kesitsel tipte gerçekleştirilmiştir.

🔖

Cite This Article

BAKIR, N., DEMİR, C., KAKAŞÇI, Ç. G. (2022). Early Detection of Gynecological Cancers and Breast Cancer During the Pandemic and Screening Tests: What Do Women Think?. Online Türk Sağlık Bilimleri Dergisi, Cilt: 7 - Sayı: 3, 499–505. https://ajindex.com/articles/585410

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382:1708-1720. doi:10.1056/NEJMoa2001017 Wang CJ, Ng CY, Brook RH. Response to COVID-19 in Taiwan: big data analytics, new technology, and proactive testing. JAMA. 2020;323(14):1341-1342. doi:10.1001/jama.2020.3151 American Cancer Society. Common questions about the new coronavirus outbreak. https://www.cancer.org/latest-news/common-questions-about-the-new-coronavirus-outbreak.html. Accessed April 26, 2020.
  2. Janda M, Paul C, Horsham C. Changes in cancer preventive behaviours, screening and diagnosis during COVID-19. Psychooncology. 2020;30(2):271-273. doi:10.1002/pon.5575 Quinn-Scoggins HD, Cannings-John R, Moriarty Y, et al. Cancer symptom experience and help-seeking behaviour during the COVID-19 pandemic in the UK: a cross-sectional population survey. BMJ Open. 2021;11(9):e053095. doi:10.1136/bmjopen-2021-053095
  3. Jones D, Neal RD, Duffy SR, Scott, SE, Whitaker KL, Brain K. Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care. The Lancet Oncology. 2020;21(6):748-750. doi:10.1016/S1470-2045(20)30242-4 Cancer Research UK. How coronavirus is impacting cancer services in the UK. 2020. https://scienceblog.cancerresearchuk.org/2020/04/21/how-coronavirus-is-impacting-cancer-services-in-the-uk/. Accessed June 2, 2021. IQVIA. Shifts in healthcare demand, delivery and care during the COVID-19 era. https://www.iqvia.com/insights/the-iqvia-institute/covid-19/shifts-in-healthcare-demand-delivery-and-care-during-the-covid-19-era. Accessed June 2, 2021. Australian Instiute of Health and Welfare (AIHW). Cancer Screening and COVID-19 in Australia. Cat. No: CAN 136. Canberra, Australia: AIHW; 2020. https://www.aihw.gov.au/reports/cancer-screening/cancer-screening-and-covid-19-in-australia-inbrief/contents/what-was-the-impact-of-covid-19-in-australia. Accessed June 2, 2021. Medscape. Three months of COVID19 may mean 80,000 missed cancer diagnoses. https://www.medscape.com/viewarticle/929986. Accessed January 14, 2021.
  4. Wernli KJ, Hubbard RA, Johnson E, et al. Patterns of colorectal cancer screening uptake in newly eligible men and women. Cancer Epidemiology and Prevention Biomarkers. 2014;23(7):1230-1237. doi:10.1158/1055-9965.EPI-13-1360 US Preventive Services Task Force. Final recommendation statement. Breast cancer: screening. https://www.uspreventiveservicestaskforce.org/uspstf/draft-update-summary/breast-cancer-s